The Effects of Novel Antidiabetic Drugs on Albuminuria in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Ya LuoKai LuGang LiuJing WangIrakoze LaurentXiaoli Zhou

Published in: Clinical drug investigation (2019)

This meta-analysis indicates that SGLT-2 inhibitors and GLP-1 receptor agonists were associated with a reduction in albuminuria compared with other conventional therapies or placebo, while DPP-4 inhibitors were not associated with albuminuria-reducing effects compared with other conventional therapies or placebo.

Keyphrases

systematic review
double blind
phase iii
meta analyses
randomized controlled trial
placebo controlled
clinical trial
case control
study protocol
open label
drug induced